ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 34278265

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.

Hunt AL and 25 others. iScience, 2021. Cited by 36 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. Papers, record 34278265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34278265

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens.
PubMed
Journal
iScience
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2024-05-05
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hunt ALAllison L
2Bateman NWNicholas W
3Barakat WWaleed
4Makohon-Moore SSasha
5Hood BLBrian L
6Conrads KAKelly A
7Zhou MMing
8Calvert VValerie
9Pierobon MMariaelena
10Loffredo JJeremy

1 to 10 of 26Source PubMed

See all 26 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
U01 CA233085NCI NIH HHSUnited StatesU01CA233085PubMed

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,468,985Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.Oncotarget2015https://conductscience.org/library/papers/26468985PubMed
225,810,134Efficient molecular subtype classification of high-grade serous ovarian cancer.J Pathol2015https://conductscience.org/library/papers/25810134PubMed
330,816,343Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.Oncogene2019https://conductscience.org/library/papers/30816343PubMed
431,871,106The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2020https://conductscience.org/library/papers/31871106PubMed
527,852,039Bevacizumab in ovarian cancer: A critical review of phase III studies.Oncotarget2017https://conductscience.org/library/papers/27852039PubMed
630,672,100PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms.J Cell Mol Med2019https://conductscience.org/library/papers/30672100PubMed
724,213,462Ovarian cancer stroma: pathophysiology and the roles in cancer development.Cancers (Basel)2012https://conductscience.org/library/papers/24213462PubMed
811,786,729The CA 125 gene: an extracellular superstructure dominated by repeat sequences.Tumour Biol2001https://conductscience.org/library/papers/11786729PubMed
928,754,819Tumor Purity as an Underlying Key Factor in Glioma.Clin Cancer Res2017https://conductscience.org/library/papers/28754819PubMed
1026,783,205The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.Int J Oncol2016https://conductscience.org/library/papers/26783205PubMed

1 to 10 of 70

See all 70 references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42,619,739Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.bioRxiv2026https://conductscience.org/library/papers/42619739PubMed
42,464,426Pan-Cancer Quantification of Driver Alteration Transmission Across Molecular Layers Reveals Limited Propagation to Protein Abundance.Int J Cancer2026https://conductscience.org/library/papers/42464426PubMed
41,868,091Laser capture microdissection.Nat Rev Methods Primers2025https://conductscience.org/library/papers/41868091PubMed
41,786,905Pan-cancer multi-omic ERBB2-HER2 characterization using next-generation sequencing and quantitative proteomics.NPJ Precis Oncol2026https://conductscience.org/library/papers/41786905PubMed
41,718,110Conserved Phosphoprotein Networks Identify Actionable Adhesion/Wnt and Metallothionein Modules in Cholangiocarcinoma.Med Sci (Basel)2026https://conductscience.org/library/papers/41718110PubMed
41,651,935Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.NPJ Precis Oncol2026https://conductscience.org/library/papers/41651935PubMed
40,826,002Proteogenomic characterization of invasive breast tumors in young women.NPJ Breast Cancer2025https://conductscience.org/library/papers/40826002PubMed
40,697,100Spatially resolved proteomics surveys the chemo-refractory proteins related to high-grade serous ovarian cancer.Clin Transl Med2025https://conductscience.org/library/papers/40697100PubMed
40,234,655Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards.NPJ Precis Oncol2025https://conductscience.org/library/papers/40234655PubMed
40,224,439dia-PASEF Proteomics of Tumor and Stroma LMD Enriched from Archived HNSCC Samples.ACS Omega2025https://conductscience.org/library/papers/40224439PubMed

1 to 10 of 30

See all 30 cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ADH1B125PubTator's text mininghttps://conductscience.org/library/genes/125NCBI Gene
AHR196PubTator's text mininghttps://conductscience.org/library/genes/196NCBI Gene
AKAP129,590PubTator's text mininghttps://conductscience.org/library/genes/9590NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
COL11A11,301PubTator's text mininghttps://conductscience.org/library/genes/1301NCBI Gene
CXCL83,576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
EPCAM4,072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
FABP42,167PubTator's text mininghttps://conductscience.org/library/genes/2167NCBI Gene

1 to 10 of 32

See all 32 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34278265

GET https://conductscience.org/api/papers/v1/34278265/authors?page=2

API referenceFor AI assistants